Secondly, BTN2A1 variants may predispose patients to CeD, via BTN2A1’s role as a ligand for DC-SIGN on DCs, which are important in CD pathogenesis in presenting gluten antigens to CD4+ αβ T cells [24,25]. This evidence concerns the gene CD4 and cranioectodermal dysplasia.